.

9

8

7

6

5

4

3

2

1

0

-

$

,

.

9

8

7

6

5

4

3

2

1

0

-

$

,

.

Why Robinhood?

You can buy or sell BeiGene and other stocks, options, ETFs, and crypto commission-free!

About

BeiGene, Ltd. American Depositary Shares, also called BeiGene, is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. Read More It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

BeiGene Reports First Quarter 2019 Financial Results

CAMBRIDGE, Mass. and BEIJING, China, May 09, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today reported recent business highlights, anticipated upcoming milestones and financial results for the first quarter of 2019.
“We made good progress in each of our business areas, including strong commercial performance ...

67

Yahoo FinanceMay 8

BeiGene Says China's Pharma Industry Going Through Positive Changes

May.08 -- John Oyler, chief executive officer of BeiGene, a Chinese cancer-drug developer, talks about the outlook for the industry and the company's strategy. BeiGene had it secondary listing in Hong Kong in August 2018 after debuting in New York in 2016. He speaks on the sidelines of J.P.Morgan:s 15th Global China Summit in Beijing on "Bloomberg Daybreak: Asia."...

34

Price Paid on Robinhood

10% Lower

Right Now

52 Week Low

$105.19

Average Price Paid

$140.91

52 Week High

$220.10

Earnings

-$4.52

-$2.17

$0.19

$2.54

Q3 2017

Q4 2017

Q1 2018

Q2 2018

Q3 2018

Q4 2018

Q1 2019

Q2 2019

Estimated

—

Actual

Expected Aug 9, After Hours

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy BGNE

Shares

Market Price$126.61

Commissions$0.00

Sign up for a Robinhood Account to buy or sell BeiGene stock and options commission-free.